Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127 | 264 | 357 | 746 | 1,183 |
| Receivables | 329 | 314 | 487 | 312 | 120 |
| TOTAL | $475 | $607 | $880 | $1,102 | $1,334 |
| Non-Current Assets | |||||
| PPE Net | 3 | 5 | 6 | 5 | 2 |
| TOTAL | $3 | $5 | $6 | $5 | $2 |
| Total Assets | $478 | $612 | $886 | $1,107 | $1,336 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 822 | 807 | 853 | 609 | 305 |
| TOTAL | $822 | $807 | $853 | $609 | $305 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $822 | $807 | $853 | $609 | $305 |
| Shareholders' Equity | |||||
| Common Shares | 22,348 | 21,479 | 22,199 | 22,434 | 22,562 |
| Retained earnings | -28,641 | -27,387 | -28,068 | -27,870 | -27,503 |
| Other shareholders' equity | 1,063 | 1,026 | 1,073 | 1,076 | 1,089 |
| TOTAL | $-344 | $-195 | $33 | $498 | $1,031 |
| Total Liabilities And Equity | $478 | $612 | $886 | $1,107 | $1,336 |